Diadelophora, a new phorid genus from central and western Brazil (Diptera: Phoridae).

Zootaxa

Universidade de So Paulo; Faculdade de Filosofia; Cincias e Letras de Ribeiro Preto; Departamento de Biologia; Av. Bandeirantes 3900; 14040901; Ribeiro Preto; SP; Brazil.

Published: February 2024

Diadelophora gen. nov, a conspicuous new genus of phorid flies is described based on two species from central and western Brazil, D. stilbella sp. nov. and D. inornata sp. nov. The new genus is positioned in the Thaumatoxena-group within the subfamily Phorinae, probably as sister group to Hypocerides Schmitz, 1915. The diagnostic features of Diadelophora are commented and illustrated, and the genus differences to Hypocerides are highlighted. The morphology of Diadelophora species is explored in detail with SEM, photos, and optical microscopy illustrations of structures of taxonomic relevance and other curious features of the genus.

Download full-text PDF

Source
http://dx.doi.org/10.11646/zootaxa.5415.1.6DOI Listing

Publication Analysis

Top Keywords

central western
8
western brazil
8
genus
5
diadelophora
4
diadelophora phorid
4
phorid genus
4
genus central
4
brazil diptera
4
diptera phoridae
4
phoridae diadelophora
4

Similar Publications

Objective: Tuberous sclerosis complex (TSC) is a monogenetic disorder associated with sustained mechanistic target of rapamycin (mTOR) activation, leading to heterogeneous clinical manifestations. Epilepsy and renal angiomyolipoma are the most important causes of morbidity in adult people with TSC (pwTSC). mTOR is a key player in inflammation, which in turn could influence TSC-related clinical manifestations.

View Article and Find Full Text PDF

Objective: The objective of this study is to examine the impact of KW-2478 combined with DDP on colorectal cancer cells both in vitro and in vivo and to elucidate the molecular mechanism of KW-2478 in colorectal cancer.

Methods: qRT-PCR and Western blot were employed to assess HSP90 mRNA and protein expression in normal intestinal epithelial and colorectal cancer cells. DLD-1 and HCT116 were selected for the experiment.

View Article and Find Full Text PDF

The Circumsporozoite Protein (PfCSP) has been used in developing the RTS,S, and R21 malaria vaccines. However, genetic polymorphisms within compromise the effectiveness of the vaccine. Thus, it is essential to continuously assess the genetic diversity of , especially when deploying it across different geographical regions.

View Article and Find Full Text PDF

Advanced hepatocellular carcinoma treatment strategies: Are transarterial approaches leading the way?

World J Gastrointest Oncol

January 2025

Department of General and Pediatric Surgery, Bolzano Central Hospital - SABES, Bolzano 39100, Trentino-Alto Adige, Italy.

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with advanced stages posing significant treatment challenges. Although hepatic arterial infusion chemotherapy (HAIC) has emerged as a promising modality for treating advanced HCC, particularly in Asian clinical practice, its adoption in Western medicine remains limited due to a lack of large-scale randomized controlled trials. This editorial reviews and comments on the meta-analysis conducted by Zhou , which evaluates the efficacy and safety of HAIC and its combination strategies for advanced HCC.

View Article and Find Full Text PDF

Background: Speckle-type POZ protein (SPOP), FAS-associated protein with death domain (FADD), and nuclear transcription factor-κB (NF-κB) have been shown to be associated with the development of prostate cancer (PCa). FADD has been shown to activate the NF-κB pathway to promote tumorigenesis, while SPOP has been shown to enhance the breakdown of FADD and inhibit the function of the NF-κB signaling pathway in non-small cell lung cancer. The existence of this mechanism has not yet been confirmed in PCa.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!